Global Hip Osteoarthritis Pain Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Hip Osteoarthritis Pain Drug is to relieve pain, and cannot slow the progress of osteoarthritis.
According to our (Global Info Research) latest study, the global Hip Osteoarthritis Pain Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Hip Osteoarthritis Pain Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Hip Osteoarthritis Pain Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Hip Osteoarthritis Pain Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Hip Osteoarthritis Pain Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Hip Osteoarthritis Pain Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hip Osteoarthritis Pain Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hip Osteoarthritis Pain Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Johnson and Johnson, GlaxoSmithKline, Bayer and Eli Lilly, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Hip Osteoarthritis Pain Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Hip Osteoarthritis Pain Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Hip Osteoarthritis Pain Drug, with price, sales, revenue and global market share of Hip Osteoarthritis Pain Drug from 2018 to 2023.
Chapter 3, the Hip Osteoarthritis Pain Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hip Osteoarthritis Pain Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Hip Osteoarthritis Pain Drug market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Hip Osteoarthritis Pain Drug.
Chapter 14 and 15, to describe Hip Osteoarthritis Pain Drug sales channel, distributors, customers, research findings and conclusion.
According to our (Global Info Research) latest study, the global Hip Osteoarthritis Pain Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Hip Osteoarthritis Pain Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Hip Osteoarthritis Pain Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Hip Osteoarthritis Pain Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Hip Osteoarthritis Pain Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Hip Osteoarthritis Pain Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hip Osteoarthritis Pain Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hip Osteoarthritis Pain Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Johnson and Johnson, GlaxoSmithKline, Bayer and Eli Lilly, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Hip Osteoarthritis Pain Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Oral
- Injection
- External
- Medical Care
- Personal Care
- Pfizer
- Johnson and Johnson
- GlaxoSmithKline
- Bayer
- Eli Lilly
- Novartis
- Sanofi
- Horizon Pharma
- Abbott
- Mylan
- Daiichi Sankyo
- TEVA
- Almatica Pharma
- Astellas Pharma
- Tide Pharmaceutical
- Iroko Pharmaceuticals
- Hengrui Pharmaceutical
- Abiogen Pharma
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Hip Osteoarthritis Pain Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Hip Osteoarthritis Pain Drug, with price, sales, revenue and global market share of Hip Osteoarthritis Pain Drug from 2018 to 2023.
Chapter 3, the Hip Osteoarthritis Pain Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hip Osteoarthritis Pain Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Hip Osteoarthritis Pain Drug market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Hip Osteoarthritis Pain Drug.
Chapter 14 and 15, to describe Hip Osteoarthritis Pain Drug sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Hip Osteoarthritis Pain Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Hip Osteoarthritis Pain Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Oral
1.3.3 Injection
1.3.4 External
1.4 Market Analysis by Application
1.4.1 Overview: Global Hip Osteoarthritis Pain Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Medical Care
1.4.3 Personal Care
1.5 Global Hip Osteoarthritis Pain Drug Market Size & Forecast
1.5.1 Global Hip Osteoarthritis Pain Drug Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Hip Osteoarthritis Pain Drug Sales Quantity (2018-2029)
1.5.3 Global Hip Osteoarthritis Pain Drug Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Hip Osteoarthritis Pain Drug Product and Services
2.1.4 Pfizer Hip Osteoarthritis Pain Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Recent Developments/Updates
2.2 Johnson and Johnson
2.2.1 Johnson and Johnson Details
2.2.2 Johnson and Johnson Major Business
2.2.3 Johnson and Johnson Hip Osteoarthritis Pain Drug Product and Services
2.2.4 Johnson and Johnson Hip Osteoarthritis Pain Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Johnson and Johnson Recent Developments/Updates
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Hip Osteoarthritis Pain Drug Product and Services
2.3.4 GlaxoSmithKline Hip Osteoarthritis Pain Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GlaxoSmithKline Recent Developments/Updates
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business
2.4.3 Bayer Hip Osteoarthritis Pain Drug Product and Services
2.4.4 Bayer Hip Osteoarthritis Pain Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Bayer Recent Developments/Updates
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business
2.5.3 Eli Lilly Hip Osteoarthritis Pain Drug Product and Services
2.5.4 Eli Lilly Hip Osteoarthritis Pain Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Eli Lilly Recent Developments/Updates
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Hip Osteoarthritis Pain Drug Product and Services
2.6.4 Novartis Hip Osteoarthritis Pain Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Novartis Recent Developments/Updates
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi Hip Osteoarthritis Pain Drug Product and Services
2.7.4 Sanofi Hip Osteoarthritis Pain Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Sanofi Recent Developments/Updates
2.8 Horizon Pharma
2.8.1 Horizon Pharma Details
2.8.2 Horizon Pharma Major Business
2.8.3 Horizon Pharma Hip Osteoarthritis Pain Drug Product and Services
2.8.4 Horizon Pharma Hip Osteoarthritis Pain Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Horizon Pharma Recent Developments/Updates
2.9 Abbott
2.9.1 Abbott Details
2.9.2 Abbott Major Business
2.9.3 Abbott Hip Osteoarthritis Pain Drug Product and Services
2.9.4 Abbott Hip Osteoarthritis Pain Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Abbott Recent Developments/Updates
2.10 Mylan
2.10.1 Mylan Details
2.10.2 Mylan Major Business
2.10.3 Mylan Hip Osteoarthritis Pain Drug Product and Services
2.10.4 Mylan Hip Osteoarthritis Pain Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Mylan Recent Developments/Updates
2.11 Daiichi Sankyo
2.11.1 Daiichi Sankyo Details
2.11.2 Daiichi Sankyo Major Business
2.11.3 Daiichi Sankyo Hip Osteoarthritis Pain Drug Product and Services
2.11.4 Daiichi Sankyo Hip Osteoarthritis Pain Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Daiichi Sankyo Recent Developments/Updates
2.12 TEVA
2.12.1 TEVA Details
2.12.2 TEVA Major Business
2.12.3 TEVA Hip Osteoarthritis Pain Drug Product and Services
2.12.4 TEVA Hip Osteoarthritis Pain Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 TEVA Recent Developments/Updates
2.13 Almatica Pharma
2.13.1 Almatica Pharma Details
2.13.2 Almatica Pharma Major Business
2.13.3 Almatica Pharma Hip Osteoarthritis Pain Drug Product and Services
2.13.4 Almatica Pharma Hip Osteoarthritis Pain Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Almatica Pharma Recent Developments/Updates
2.14 Astellas Pharma
2.14.1 Astellas Pharma Details
2.14.2 Astellas Pharma Major Business
2.14.3 Astellas Pharma Hip Osteoarthritis Pain Drug Product and Services
2.14.4 Astellas Pharma Hip Osteoarthritis Pain Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Astellas Pharma Recent Developments/Updates
2.15 Tide Pharmaceutical
2.15.1 Tide Pharmaceutical Details
2.15.2 Tide Pharmaceutical Major Business
2.15.3 Tide Pharmaceutical Hip Osteoarthritis Pain Drug Product and Services
2.15.4 Tide Pharmaceutical Hip Osteoarthritis Pain Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Tide Pharmaceutical Recent Developments/Updates
2.16 Iroko Pharmaceuticals
2.16.1 Iroko Pharmaceuticals Details
2.16.2 Iroko Pharmaceuticals Major Business
2.16.3 Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Product and Services
2.16.4 Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Iroko Pharmaceuticals Recent Developments/Updates
2.17 Hengrui Pharmaceutical
2.17.1 Hengrui Pharmaceutical Details
2.17.2 Hengrui Pharmaceutical Major Business
2.17.3 Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Product and Services
2.17.4 Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Hengrui Pharmaceutical Recent Developments/Updates
2.18 Abiogen Pharma
2.18.1 Abiogen Pharma Details
2.18.2 Abiogen Pharma Major Business
2.18.3 Abiogen Pharma Hip Osteoarthritis Pain Drug Product and Services
2.18.4 Abiogen Pharma Hip Osteoarthritis Pain Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Abiogen Pharma Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: HIP OSTEOARTHRITIS PAIN DRUG BY MANUFACTURER
3.1 Global Hip Osteoarthritis Pain Drug Sales Quantity by Manufacturer (2018-2023)
3.2 Global Hip Osteoarthritis Pain Drug Revenue by Manufacturer (2018-2023)
3.3 Global Hip Osteoarthritis Pain Drug Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Hip Osteoarthritis Pain Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Hip Osteoarthritis Pain Drug Manufacturer Market Share in 2022
3.4.2 Top 6 Hip Osteoarthritis Pain Drug Manufacturer Market Share in 2022
3.5 Hip Osteoarthritis Pain Drug Market: Overall Company Footprint Analysis
3.5.1 Hip Osteoarthritis Pain Drug Market: Region Footprint
3.5.2 Hip Osteoarthritis Pain Drug Market: Company Product Type Footprint
3.5.3 Hip Osteoarthritis Pain Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Hip Osteoarthritis Pain Drug Market Size by Region
4.1.1 Global Hip Osteoarthritis Pain Drug Sales Quantity by Region (2018-2029)
4.1.2 Global Hip Osteoarthritis Pain Drug Consumption Value by Region (2018-2029)
4.1.3 Global Hip Osteoarthritis Pain Drug Average Price by Region (2018-2029)
4.2 North America Hip Osteoarthritis Pain Drug Consumption Value (2018-2029)
4.3 Europe Hip Osteoarthritis Pain Drug Consumption Value (2018-2029)
4.4 Asia-Pacific Hip Osteoarthritis Pain Drug Consumption Value (2018-2029)
4.5 South America Hip Osteoarthritis Pain Drug Consumption Value (2018-2029)
4.6 Middle East and Africa Hip Osteoarthritis Pain Drug Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Hip Osteoarthritis Pain Drug Sales Quantity by Type (2018-2029)
5.2 Global Hip Osteoarthritis Pain Drug Consumption Value by Type (2018-2029)
5.3 Global Hip Osteoarthritis Pain Drug Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Hip Osteoarthritis Pain Drug Sales Quantity by Application (2018-2029)
6.2 Global Hip Osteoarthritis Pain Drug Consumption Value by Application (2018-2029)
6.3 Global Hip Osteoarthritis Pain Drug Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Hip Osteoarthritis Pain Drug Sales Quantity by Type (2018-2029)
7.2 North America Hip Osteoarthritis Pain Drug Sales Quantity by Application (2018-2029)
7.3 North America Hip Osteoarthritis Pain Drug Market Size by Country
7.3.1 North America Hip Osteoarthritis Pain Drug Sales Quantity by Country (2018-2029)
7.3.2 North America Hip Osteoarthritis Pain Drug Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Hip Osteoarthritis Pain Drug Sales Quantity by Type (2018-2029)
8.2 Europe Hip Osteoarthritis Pain Drug Sales Quantity by Application (2018-2029)
8.3 Europe Hip Osteoarthritis Pain Drug Market Size by Country
8.3.1 Europe Hip Osteoarthritis Pain Drug Sales Quantity by Country (2018-2029)
8.3.2 Europe Hip Osteoarthritis Pain Drug Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Hip Osteoarthritis Pain Drug Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Hip Osteoarthritis Pain Drug Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Hip Osteoarthritis Pain Drug Market Size by Region
9.3.1 Asia-Pacific Hip Osteoarthritis Pain Drug Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Hip Osteoarthritis Pain Drug Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Hip Osteoarthritis Pain Drug Sales Quantity by Type (2018-2029)
10.2 South America Hip Osteoarthritis Pain Drug Sales Quantity by Application (2018-2029)
10.3 South America Hip Osteoarthritis Pain Drug Market Size by Country
10.3.1 South America Hip Osteoarthritis Pain Drug Sales Quantity by Country (2018-2029)
10.3.2 South America Hip Osteoarthritis Pain Drug Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Hip Osteoarthritis Pain Drug Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Hip Osteoarthritis Pain Drug Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Hip Osteoarthritis Pain Drug Market Size by Country
11.3.1 Middle East & Africa Hip Osteoarthritis Pain Drug Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Hip Osteoarthritis Pain Drug Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Hip Osteoarthritis Pain Drug Market Drivers
12.2 Hip Osteoarthritis Pain Drug Market Restraints
12.3 Hip Osteoarthritis Pain Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Hip Osteoarthritis Pain Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Hip Osteoarthritis Pain Drug
13.3 Hip Osteoarthritis Pain Drug Production Process
13.4 Hip Osteoarthritis Pain Drug Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Hip Osteoarthritis Pain Drug Typical Distributors
14.3 Hip Osteoarthritis Pain Drug Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Hip Osteoarthritis Pain Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Hip Osteoarthritis Pain Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Oral
1.3.3 Injection
1.3.4 External
1.4 Market Analysis by Application
1.4.1 Overview: Global Hip Osteoarthritis Pain Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Medical Care
1.4.3 Personal Care
1.5 Global Hip Osteoarthritis Pain Drug Market Size & Forecast
1.5.1 Global Hip Osteoarthritis Pain Drug Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Hip Osteoarthritis Pain Drug Sales Quantity (2018-2029)
1.5.3 Global Hip Osteoarthritis Pain Drug Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Hip Osteoarthritis Pain Drug Product and Services
2.1.4 Pfizer Hip Osteoarthritis Pain Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Recent Developments/Updates
2.2 Johnson and Johnson
2.2.1 Johnson and Johnson Details
2.2.2 Johnson and Johnson Major Business
2.2.3 Johnson and Johnson Hip Osteoarthritis Pain Drug Product and Services
2.2.4 Johnson and Johnson Hip Osteoarthritis Pain Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Johnson and Johnson Recent Developments/Updates
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Hip Osteoarthritis Pain Drug Product and Services
2.3.4 GlaxoSmithKline Hip Osteoarthritis Pain Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 GlaxoSmithKline Recent Developments/Updates
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business
2.4.3 Bayer Hip Osteoarthritis Pain Drug Product and Services
2.4.4 Bayer Hip Osteoarthritis Pain Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Bayer Recent Developments/Updates
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business
2.5.3 Eli Lilly Hip Osteoarthritis Pain Drug Product and Services
2.5.4 Eli Lilly Hip Osteoarthritis Pain Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Eli Lilly Recent Developments/Updates
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Hip Osteoarthritis Pain Drug Product and Services
2.6.4 Novartis Hip Osteoarthritis Pain Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Novartis Recent Developments/Updates
2.7 Sanofi
2.7.1 Sanofi Details
2.7.2 Sanofi Major Business
2.7.3 Sanofi Hip Osteoarthritis Pain Drug Product and Services
2.7.4 Sanofi Hip Osteoarthritis Pain Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Sanofi Recent Developments/Updates
2.8 Horizon Pharma
2.8.1 Horizon Pharma Details
2.8.2 Horizon Pharma Major Business
2.8.3 Horizon Pharma Hip Osteoarthritis Pain Drug Product and Services
2.8.4 Horizon Pharma Hip Osteoarthritis Pain Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Horizon Pharma Recent Developments/Updates
2.9 Abbott
2.9.1 Abbott Details
2.9.2 Abbott Major Business
2.9.3 Abbott Hip Osteoarthritis Pain Drug Product and Services
2.9.4 Abbott Hip Osteoarthritis Pain Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Abbott Recent Developments/Updates
2.10 Mylan
2.10.1 Mylan Details
2.10.2 Mylan Major Business
2.10.3 Mylan Hip Osteoarthritis Pain Drug Product and Services
2.10.4 Mylan Hip Osteoarthritis Pain Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Mylan Recent Developments/Updates
2.11 Daiichi Sankyo
2.11.1 Daiichi Sankyo Details
2.11.2 Daiichi Sankyo Major Business
2.11.3 Daiichi Sankyo Hip Osteoarthritis Pain Drug Product and Services
2.11.4 Daiichi Sankyo Hip Osteoarthritis Pain Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Daiichi Sankyo Recent Developments/Updates
2.12 TEVA
2.12.1 TEVA Details
2.12.2 TEVA Major Business
2.12.3 TEVA Hip Osteoarthritis Pain Drug Product and Services
2.12.4 TEVA Hip Osteoarthritis Pain Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 TEVA Recent Developments/Updates
2.13 Almatica Pharma
2.13.1 Almatica Pharma Details
2.13.2 Almatica Pharma Major Business
2.13.3 Almatica Pharma Hip Osteoarthritis Pain Drug Product and Services
2.13.4 Almatica Pharma Hip Osteoarthritis Pain Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Almatica Pharma Recent Developments/Updates
2.14 Astellas Pharma
2.14.1 Astellas Pharma Details
2.14.2 Astellas Pharma Major Business
2.14.3 Astellas Pharma Hip Osteoarthritis Pain Drug Product and Services
2.14.4 Astellas Pharma Hip Osteoarthritis Pain Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Astellas Pharma Recent Developments/Updates
2.15 Tide Pharmaceutical
2.15.1 Tide Pharmaceutical Details
2.15.2 Tide Pharmaceutical Major Business
2.15.3 Tide Pharmaceutical Hip Osteoarthritis Pain Drug Product and Services
2.15.4 Tide Pharmaceutical Hip Osteoarthritis Pain Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Tide Pharmaceutical Recent Developments/Updates
2.16 Iroko Pharmaceuticals
2.16.1 Iroko Pharmaceuticals Details
2.16.2 Iroko Pharmaceuticals Major Business
2.16.3 Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Product and Services
2.16.4 Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Iroko Pharmaceuticals Recent Developments/Updates
2.17 Hengrui Pharmaceutical
2.17.1 Hengrui Pharmaceutical Details
2.17.2 Hengrui Pharmaceutical Major Business
2.17.3 Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Product and Services
2.17.4 Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Hengrui Pharmaceutical Recent Developments/Updates
2.18 Abiogen Pharma
2.18.1 Abiogen Pharma Details
2.18.2 Abiogen Pharma Major Business
2.18.3 Abiogen Pharma Hip Osteoarthritis Pain Drug Product and Services
2.18.4 Abiogen Pharma Hip Osteoarthritis Pain Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Abiogen Pharma Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: HIP OSTEOARTHRITIS PAIN DRUG BY MANUFACTURER
3.1 Global Hip Osteoarthritis Pain Drug Sales Quantity by Manufacturer (2018-2023)
3.2 Global Hip Osteoarthritis Pain Drug Revenue by Manufacturer (2018-2023)
3.3 Global Hip Osteoarthritis Pain Drug Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Hip Osteoarthritis Pain Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Hip Osteoarthritis Pain Drug Manufacturer Market Share in 2022
3.4.2 Top 6 Hip Osteoarthritis Pain Drug Manufacturer Market Share in 2022
3.5 Hip Osteoarthritis Pain Drug Market: Overall Company Footprint Analysis
3.5.1 Hip Osteoarthritis Pain Drug Market: Region Footprint
3.5.2 Hip Osteoarthritis Pain Drug Market: Company Product Type Footprint
3.5.3 Hip Osteoarthritis Pain Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Hip Osteoarthritis Pain Drug Market Size by Region
4.1.1 Global Hip Osteoarthritis Pain Drug Sales Quantity by Region (2018-2029)
4.1.2 Global Hip Osteoarthritis Pain Drug Consumption Value by Region (2018-2029)
4.1.3 Global Hip Osteoarthritis Pain Drug Average Price by Region (2018-2029)
4.2 North America Hip Osteoarthritis Pain Drug Consumption Value (2018-2029)
4.3 Europe Hip Osteoarthritis Pain Drug Consumption Value (2018-2029)
4.4 Asia-Pacific Hip Osteoarthritis Pain Drug Consumption Value (2018-2029)
4.5 South America Hip Osteoarthritis Pain Drug Consumption Value (2018-2029)
4.6 Middle East and Africa Hip Osteoarthritis Pain Drug Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Hip Osteoarthritis Pain Drug Sales Quantity by Type (2018-2029)
5.2 Global Hip Osteoarthritis Pain Drug Consumption Value by Type (2018-2029)
5.3 Global Hip Osteoarthritis Pain Drug Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Hip Osteoarthritis Pain Drug Sales Quantity by Application (2018-2029)
6.2 Global Hip Osteoarthritis Pain Drug Consumption Value by Application (2018-2029)
6.3 Global Hip Osteoarthritis Pain Drug Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Hip Osteoarthritis Pain Drug Sales Quantity by Type (2018-2029)
7.2 North America Hip Osteoarthritis Pain Drug Sales Quantity by Application (2018-2029)
7.3 North America Hip Osteoarthritis Pain Drug Market Size by Country
7.3.1 North America Hip Osteoarthritis Pain Drug Sales Quantity by Country (2018-2029)
7.3.2 North America Hip Osteoarthritis Pain Drug Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Hip Osteoarthritis Pain Drug Sales Quantity by Type (2018-2029)
8.2 Europe Hip Osteoarthritis Pain Drug Sales Quantity by Application (2018-2029)
8.3 Europe Hip Osteoarthritis Pain Drug Market Size by Country
8.3.1 Europe Hip Osteoarthritis Pain Drug Sales Quantity by Country (2018-2029)
8.3.2 Europe Hip Osteoarthritis Pain Drug Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Hip Osteoarthritis Pain Drug Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Hip Osteoarthritis Pain Drug Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Hip Osteoarthritis Pain Drug Market Size by Region
9.3.1 Asia-Pacific Hip Osteoarthritis Pain Drug Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Hip Osteoarthritis Pain Drug Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Hip Osteoarthritis Pain Drug Sales Quantity by Type (2018-2029)
10.2 South America Hip Osteoarthritis Pain Drug Sales Quantity by Application (2018-2029)
10.3 South America Hip Osteoarthritis Pain Drug Market Size by Country
10.3.1 South America Hip Osteoarthritis Pain Drug Sales Quantity by Country (2018-2029)
10.3.2 South America Hip Osteoarthritis Pain Drug Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Hip Osteoarthritis Pain Drug Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Hip Osteoarthritis Pain Drug Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Hip Osteoarthritis Pain Drug Market Size by Country
11.3.1 Middle East & Africa Hip Osteoarthritis Pain Drug Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Hip Osteoarthritis Pain Drug Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Hip Osteoarthritis Pain Drug Market Drivers
12.2 Hip Osteoarthritis Pain Drug Market Restraints
12.3 Hip Osteoarthritis Pain Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Hip Osteoarthritis Pain Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Hip Osteoarthritis Pain Drug
13.3 Hip Osteoarthritis Pain Drug Production Process
13.4 Hip Osteoarthritis Pain Drug Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Hip Osteoarthritis Pain Drug Typical Distributors
14.3 Hip Osteoarthritis Pain Drug Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Hip Osteoarthritis Pain Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Hip Osteoarthritis Pain Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Hip Osteoarthritis Pain Drug Product and Services
Table 6. Pfizer Hip Osteoarthritis Pain Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Pfizer Recent Developments/Updates
Table 8. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 9. Johnson and Johnson Major Business
Table 10. Johnson and Johnson Hip Osteoarthritis Pain Drug Product and Services
Table 11. Johnson and Johnson Hip Osteoarthritis Pain Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Johnson and Johnson Recent Developments/Updates
Table 13. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 14. GlaxoSmithKline Major Business
Table 15. GlaxoSmithKline Hip Osteoarthritis Pain Drug Product and Services
Table 16. GlaxoSmithKline Hip Osteoarthritis Pain Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. GlaxoSmithKline Recent Developments/Updates
Table 18. Bayer Basic Information, Manufacturing Base and Competitors
Table 19. Bayer Major Business
Table 20. Bayer Hip Osteoarthritis Pain Drug Product and Services
Table 21. Bayer Hip Osteoarthritis Pain Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Bayer Recent Developments/Updates
Table 23. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 24. Eli Lilly Major Business
Table 25. Eli Lilly Hip Osteoarthritis Pain Drug Product and Services
Table 26. Eli Lilly Hip Osteoarthritis Pain Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Eli Lilly Recent Developments/Updates
Table 28. Novartis Basic Information, Manufacturing Base and Competitors
Table 29. Novartis Major Business
Table 30. Novartis Hip Osteoarthritis Pain Drug Product and Services
Table 31. Novartis Hip Osteoarthritis Pain Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Novartis Recent Developments/Updates
Table 33. Sanofi Basic Information, Manufacturing Base and Competitors
Table 34. Sanofi Major Business
Table 35. Sanofi Hip Osteoarthritis Pain Drug Product and Services
Table 36. Sanofi Hip Osteoarthritis Pain Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Sanofi Recent Developments/Updates
Table 38. Horizon Pharma Basic Information, Manufacturing Base and Competitors
Table 39. Horizon Pharma Major Business
Table 40. Horizon Pharma Hip Osteoarthritis Pain Drug Product and Services
Table 41. Horizon Pharma Hip Osteoarthritis Pain Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Horizon Pharma Recent Developments/Updates
Table 43. Abbott Basic Information, Manufacturing Base and Competitors
Table 44. Abbott Major Business
Table 45. Abbott Hip Osteoarthritis Pain Drug Product and Services
Table 46. Abbott Hip Osteoarthritis Pain Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Abbott Recent Developments/Updates
Table 48. Mylan Basic Information, Manufacturing Base and Competitors
Table 49. Mylan Major Business
Table 50. Mylan Hip Osteoarthritis Pain Drug Product and Services
Table 51. Mylan Hip Osteoarthritis Pain Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Mylan Recent Developments/Updates
Table 53. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 54. Daiichi Sankyo Major Business
Table 55. Daiichi Sankyo Hip Osteoarthritis Pain Drug Product and Services
Table 56. Daiichi Sankyo Hip Osteoarthritis Pain Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Daiichi Sankyo Recent Developments/Updates
Table 58. TEVA Basic Information, Manufacturing Base and Competitors
Table 59. TEVA Major Business
Table 60. TEVA Hip Osteoarthritis Pain Drug Product and Services
Table 61. TEVA Hip Osteoarthritis Pain Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. TEVA Recent Developments/Updates
Table 63. Almatica Pharma Basic Information, Manufacturing Base and Competitors
Table 64. Almatica Pharma Major Business
Table 65. Almatica Pharma Hip Osteoarthritis Pain Drug Product and Services
Table 66. Almatica Pharma Hip Osteoarthritis Pain Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Almatica Pharma Recent Developments/Updates
Table 68. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 69. Astellas Pharma Major Business
Table 70. Astellas Pharma Hip Osteoarthritis Pain Drug Product and Services
Table 71. Astellas Pharma Hip Osteoarthritis Pain Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Astellas Pharma Recent Developments/Updates
Table 73. Tide Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Tide Pharmaceutical Major Business
Table 75. Tide Pharmaceutical Hip Osteoarthritis Pain Drug Product and Services
Table 76. Tide Pharmaceutical Hip Osteoarthritis Pain Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Tide Pharmaceutical Recent Developments/Updates
Table 78. Iroko Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 79. Iroko Pharmaceuticals Major Business
Table 80. Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Product and Services
Table 81. Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Iroko Pharmaceuticals Recent Developments/Updates
Table 83. Hengrui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 84. Hengrui Pharmaceutical Major Business
Table 85. Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Product and Services
Table 86. Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Hengrui Pharmaceutical Recent Developments/Updates
Table 88. Abiogen Pharma Basic Information, Manufacturing Base and Competitors
Table 89. Abiogen Pharma Major Business
Table 90. Abiogen Pharma Hip Osteoarthritis Pain Drug Product and Services
Table 91. Abiogen Pharma Hip Osteoarthritis Pain Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Abiogen Pharma Recent Developments/Updates
Table 93. Global Hip Osteoarthritis Pain Drug Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 94. Global Hip Osteoarthritis Pain Drug Revenue by Manufacturer (2018-2023) & (USD Million)
Table 95. Global Hip Osteoarthritis Pain Drug Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 96. Market Position of Manufacturers in Hip Osteoarthritis Pain Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 97. Head Office and Hip Osteoarthritis Pain Drug Production Site of Key Manufacturer
Table 98. Hip Osteoarthritis Pain Drug Market: Company Product Type Footprint
Table 99. Hip Osteoarthritis Pain Drug Market: Company Product Application Footprint
Table 100. Hip Osteoarthritis Pain Drug New Market Entrants and Barriers to Market Entry
Table 101. Hip Osteoarthritis Pain Drug Mergers, Acquisition, Agreements, and Collaborations
Table 102. Global Hip Osteoarthritis Pain Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 103. Global Hip Osteoarthritis Pain Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 104. Global Hip Osteoarthritis Pain Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 105. Global Hip Osteoarthritis Pain Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 106. Global Hip Osteoarthritis Pain Drug Average Price by Region (2018-2023) & (USD/Unit)
Table 107. Global Hip Osteoarthritis Pain Drug Average Price by Region (2024-2029) & (USD/Unit)
Table 108. Global Hip Osteoarthritis Pain Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 109. Global Hip Osteoarthritis Pain Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 110. Global Hip Osteoarthritis Pain Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 111. Global Hip Osteoarthritis Pain Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 112. Global Hip Osteoarthritis Pain Drug Average Price by Type (2018-2023) & (USD/Unit)
Table 113. Global Hip Osteoarthritis Pain Drug Average Price by Type (2024-2029) & (USD/Unit)
Table 114. Global Hip Osteoarthritis Pain Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Global Hip Osteoarthritis Pain Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Global Hip Osteoarthritis Pain Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 117. Global Hip Osteoarthritis Pain Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 118. Global Hip Osteoarthritis Pain Drug Average Price by Application (2018-2023) & (USD/Unit)
Table 119. Global Hip Osteoarthritis Pain Drug Average Price by Application (2024-2029) & (USD/Unit)
Table 120. North America Hip Osteoarthritis Pain Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 121. North America Hip Osteoarthritis Pain Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 122. North America Hip Osteoarthritis Pain Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 123. North America Hip Osteoarthritis Pain Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 124. North America Hip Osteoarthritis Pain Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 125. North America Hip Osteoarthritis Pain Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 126. North America Hip Osteoarthritis Pain Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 127. North America Hip Osteoarthritis Pain Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 128. Europe Hip Osteoarthritis Pain Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 129. Europe Hip Osteoarthritis Pain Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 130. Europe Hip Osteoarthritis Pain Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 131. Europe Hip Osteoarthritis Pain Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 132. Europe Hip Osteoarthritis Pain Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 133. Europe Hip Osteoarthritis Pain Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 134. Europe Hip Osteoarthritis Pain Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 135. Europe Hip Osteoarthritis Pain Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 136. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 137. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 138. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 139. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 140. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 141. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 142. Asia-Pacific Hip Osteoarthritis Pain Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 143. Asia-Pacific Hip Osteoarthritis Pain Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 144. South America Hip Osteoarthritis Pain Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 145. South America Hip Osteoarthritis Pain Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 146. South America Hip Osteoarthritis Pain Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 147. South America Hip Osteoarthritis Pain Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 148. South America Hip Osteoarthritis Pain Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 149. South America Hip Osteoarthritis Pain Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 150. South America Hip Osteoarthritis Pain Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 151. South America Hip Osteoarthritis Pain Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 152. Middle East & Africa Hip Osteoarthritis Pain Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 153. Middle East & Africa Hip Osteoarthritis Pain Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 154. Middle East & Africa Hip Osteoarthritis Pain Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 155. Middle East & Africa Hip Osteoarthritis Pain Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 156. Middle East & Africa Hip Osteoarthritis Pain Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 157. Middle East & Africa Hip Osteoarthritis Pain Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 158. Middle East & Africa Hip Osteoarthritis Pain Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 159. Middle East & Africa Hip Osteoarthritis Pain Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 160. Hip Osteoarthritis Pain Drug Raw Material
Table 161. Key Manufacturers of Hip Osteoarthritis Pain Drug Raw Materials
Table 162. Hip Osteoarthritis Pain Drug Typical Distributors
Table 163. Hip Osteoarthritis Pain Drug Typical Customers
Table 1. Global Hip Osteoarthritis Pain Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Hip Osteoarthritis Pain Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Hip Osteoarthritis Pain Drug Product and Services
Table 6. Pfizer Hip Osteoarthritis Pain Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Pfizer Recent Developments/Updates
Table 8. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 9. Johnson and Johnson Major Business
Table 10. Johnson and Johnson Hip Osteoarthritis Pain Drug Product and Services
Table 11. Johnson and Johnson Hip Osteoarthritis Pain Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Johnson and Johnson Recent Developments/Updates
Table 13. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 14. GlaxoSmithKline Major Business
Table 15. GlaxoSmithKline Hip Osteoarthritis Pain Drug Product and Services
Table 16. GlaxoSmithKline Hip Osteoarthritis Pain Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. GlaxoSmithKline Recent Developments/Updates
Table 18. Bayer Basic Information, Manufacturing Base and Competitors
Table 19. Bayer Major Business
Table 20. Bayer Hip Osteoarthritis Pain Drug Product and Services
Table 21. Bayer Hip Osteoarthritis Pain Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Bayer Recent Developments/Updates
Table 23. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 24. Eli Lilly Major Business
Table 25. Eli Lilly Hip Osteoarthritis Pain Drug Product and Services
Table 26. Eli Lilly Hip Osteoarthritis Pain Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Eli Lilly Recent Developments/Updates
Table 28. Novartis Basic Information, Manufacturing Base and Competitors
Table 29. Novartis Major Business
Table 30. Novartis Hip Osteoarthritis Pain Drug Product and Services
Table 31. Novartis Hip Osteoarthritis Pain Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Novartis Recent Developments/Updates
Table 33. Sanofi Basic Information, Manufacturing Base and Competitors
Table 34. Sanofi Major Business
Table 35. Sanofi Hip Osteoarthritis Pain Drug Product and Services
Table 36. Sanofi Hip Osteoarthritis Pain Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Sanofi Recent Developments/Updates
Table 38. Horizon Pharma Basic Information, Manufacturing Base and Competitors
Table 39. Horizon Pharma Major Business
Table 40. Horizon Pharma Hip Osteoarthritis Pain Drug Product and Services
Table 41. Horizon Pharma Hip Osteoarthritis Pain Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Horizon Pharma Recent Developments/Updates
Table 43. Abbott Basic Information, Manufacturing Base and Competitors
Table 44. Abbott Major Business
Table 45. Abbott Hip Osteoarthritis Pain Drug Product and Services
Table 46. Abbott Hip Osteoarthritis Pain Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Abbott Recent Developments/Updates
Table 48. Mylan Basic Information, Manufacturing Base and Competitors
Table 49. Mylan Major Business
Table 50. Mylan Hip Osteoarthritis Pain Drug Product and Services
Table 51. Mylan Hip Osteoarthritis Pain Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Mylan Recent Developments/Updates
Table 53. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 54. Daiichi Sankyo Major Business
Table 55. Daiichi Sankyo Hip Osteoarthritis Pain Drug Product and Services
Table 56. Daiichi Sankyo Hip Osteoarthritis Pain Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Daiichi Sankyo Recent Developments/Updates
Table 58. TEVA Basic Information, Manufacturing Base and Competitors
Table 59. TEVA Major Business
Table 60. TEVA Hip Osteoarthritis Pain Drug Product and Services
Table 61. TEVA Hip Osteoarthritis Pain Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. TEVA Recent Developments/Updates
Table 63. Almatica Pharma Basic Information, Manufacturing Base and Competitors
Table 64. Almatica Pharma Major Business
Table 65. Almatica Pharma Hip Osteoarthritis Pain Drug Product and Services
Table 66. Almatica Pharma Hip Osteoarthritis Pain Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Almatica Pharma Recent Developments/Updates
Table 68. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 69. Astellas Pharma Major Business
Table 70. Astellas Pharma Hip Osteoarthritis Pain Drug Product and Services
Table 71. Astellas Pharma Hip Osteoarthritis Pain Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Astellas Pharma Recent Developments/Updates
Table 73. Tide Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Tide Pharmaceutical Major Business
Table 75. Tide Pharmaceutical Hip Osteoarthritis Pain Drug Product and Services
Table 76. Tide Pharmaceutical Hip Osteoarthritis Pain Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Tide Pharmaceutical Recent Developments/Updates
Table 78. Iroko Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 79. Iroko Pharmaceuticals Major Business
Table 80. Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Product and Services
Table 81. Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Iroko Pharmaceuticals Recent Developments/Updates
Table 83. Hengrui Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 84. Hengrui Pharmaceutical Major Business
Table 85. Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Product and Services
Table 86. Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Hengrui Pharmaceutical Recent Developments/Updates
Table 88. Abiogen Pharma Basic Information, Manufacturing Base and Competitors
Table 89. Abiogen Pharma Major Business
Table 90. Abiogen Pharma Hip Osteoarthritis Pain Drug Product and Services
Table 91. Abiogen Pharma Hip Osteoarthritis Pain Drug Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Abiogen Pharma Recent Developments/Updates
Table 93. Global Hip Osteoarthritis Pain Drug Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 94. Global Hip Osteoarthritis Pain Drug Revenue by Manufacturer (2018-2023) & (USD Million)
Table 95. Global Hip Osteoarthritis Pain Drug Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 96. Market Position of Manufacturers in Hip Osteoarthritis Pain Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 97. Head Office and Hip Osteoarthritis Pain Drug Production Site of Key Manufacturer
Table 98. Hip Osteoarthritis Pain Drug Market: Company Product Type Footprint
Table 99. Hip Osteoarthritis Pain Drug Market: Company Product Application Footprint
Table 100. Hip Osteoarthritis Pain Drug New Market Entrants and Barriers to Market Entry
Table 101. Hip Osteoarthritis Pain Drug Mergers, Acquisition, Agreements, and Collaborations
Table 102. Global Hip Osteoarthritis Pain Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 103. Global Hip Osteoarthritis Pain Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 104. Global Hip Osteoarthritis Pain Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 105. Global Hip Osteoarthritis Pain Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 106. Global Hip Osteoarthritis Pain Drug Average Price by Region (2018-2023) & (USD/Unit)
Table 107. Global Hip Osteoarthritis Pain Drug Average Price by Region (2024-2029) & (USD/Unit)
Table 108. Global Hip Osteoarthritis Pain Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 109. Global Hip Osteoarthritis Pain Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 110. Global Hip Osteoarthritis Pain Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 111. Global Hip Osteoarthritis Pain Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 112. Global Hip Osteoarthritis Pain Drug Average Price by Type (2018-2023) & (USD/Unit)
Table 113. Global Hip Osteoarthritis Pain Drug Average Price by Type (2024-2029) & (USD/Unit)
Table 114. Global Hip Osteoarthritis Pain Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Global Hip Osteoarthritis Pain Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Global Hip Osteoarthritis Pain Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 117. Global Hip Osteoarthritis Pain Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 118. Global Hip Osteoarthritis Pain Drug Average Price by Application (2018-2023) & (USD/Unit)
Table 119. Global Hip Osteoarthritis Pain Drug Average Price by Application (2024-2029) & (USD/Unit)
Table 120. North America Hip Osteoarthritis Pain Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 121. North America Hip Osteoarthritis Pain Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 122. North America Hip Osteoarthritis Pain Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 123. North America Hip Osteoarthritis Pain Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 124. North America Hip Osteoarthritis Pain Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 125. North America Hip Osteoarthritis Pain Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 126. North America Hip Osteoarthritis Pain Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 127. North America Hip Osteoarthritis Pain Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 128. Europe Hip Osteoarthritis Pain Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 129. Europe Hip Osteoarthritis Pain Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 130. Europe Hip Osteoarthritis Pain Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 131. Europe Hip Osteoarthritis Pain Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 132. Europe Hip Osteoarthritis Pain Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 133. Europe Hip Osteoarthritis Pain Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 134. Europe Hip Osteoarthritis Pain Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 135. Europe Hip Osteoarthritis Pain Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 136. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 137. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 138. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 139. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 140. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 141. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 142. Asia-Pacific Hip Osteoarthritis Pain Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 143. Asia-Pacific Hip Osteoarthritis Pain Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 144. South America Hip Osteoarthritis Pain Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 145. South America Hip Osteoarthritis Pain Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 146. South America Hip Osteoarthritis Pain Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 147. South America Hip Osteoarthritis Pain Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 148. South America Hip Osteoarthritis Pain Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 149. South America Hip Osteoarthritis Pain Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 150. South America Hip Osteoarthritis Pain Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 151. South America Hip Osteoarthritis Pain Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 152. Middle East & Africa Hip Osteoarthritis Pain Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 153. Middle East & Africa Hip Osteoarthritis Pain Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 154. Middle East & Africa Hip Osteoarthritis Pain Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 155. Middle East & Africa Hip Osteoarthritis Pain Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 156. Middle East & Africa Hip Osteoarthritis Pain Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 157. Middle East & Africa Hip Osteoarthritis Pain Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 158. Middle East & Africa Hip Osteoarthritis Pain Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 159. Middle East & Africa Hip Osteoarthritis Pain Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 160. Hip Osteoarthritis Pain Drug Raw Material
Table 161. Key Manufacturers of Hip Osteoarthritis Pain Drug Raw Materials
Table 162. Hip Osteoarthritis Pain Drug Typical Distributors
Table 163. Hip Osteoarthritis Pain Drug Typical Customers
LIST OF FIGURES
Figure 1. Hip Osteoarthritis Pain Drug Picture
Figure 2. Global Hip Osteoarthritis Pain Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Hip Osteoarthritis Pain Drug Consumption Value Market Share by Type in 2022
Figure 4. Oral Examples
Figure 5. Injection Examples
Figure 6. External Examples
Figure 7. Global Hip Osteoarthritis Pain Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Hip Osteoarthritis Pain Drug Consumption Value Market Share by Application in 2022
Figure 9. Medical Care Examples
Figure 10. Personal Care Examples
Figure 11. Global Hip Osteoarthritis Pain Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Hip Osteoarthritis Pain Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Hip Osteoarthritis Pain Drug Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Hip Osteoarthritis Pain Drug Average Price (2018-2029) & (USD/Unit)
Figure 15. Global Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Hip Osteoarthritis Pain Drug Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Hip Osteoarthritis Pain Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Hip Osteoarthritis Pain Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Hip Osteoarthritis Pain Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Hip Osteoarthritis Pain Drug Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Hip Osteoarthritis Pain Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Hip Osteoarthritis Pain Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Hip Osteoarthritis Pain Drug Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Hip Osteoarthritis Pain Drug Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Hip Osteoarthritis Pain Drug Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Hip Osteoarthritis Pain Drug Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Hip Osteoarthritis Pain Drug Average Price by Type (2018-2029) & (USD/Unit)
Figure 30. Global Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Hip Osteoarthritis Pain Drug Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Hip Osteoarthritis Pain Drug Average Price by Application (2018-2029) & (USD/Unit)
Figure 33. North America Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Hip Osteoarthritis Pain Drug Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Hip Osteoarthritis Pain Drug Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Hip Osteoarthritis Pain Drug Consumption Value Market Share by Region (2018-2029)
Figure 53. China Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Hip Osteoarthritis Pain Drug Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Hip Osteoarthritis Pain Drug Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Hip Osteoarthritis Pain Drug Market Drivers
Figure 74. Hip Osteoarthritis Pain Drug Market Restraints
Figure 75. Hip Osteoarthritis Pain Drug Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Hip Osteoarthritis Pain Drug in 2022
Figure 78. Manufacturing Process Analysis of Hip Osteoarthritis Pain Drug
Figure 79. Hip Osteoarthritis Pain Drug Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Hip Osteoarthritis Pain Drug Picture
Figure 2. Global Hip Osteoarthritis Pain Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Hip Osteoarthritis Pain Drug Consumption Value Market Share by Type in 2022
Figure 4. Oral Examples
Figure 5. Injection Examples
Figure 6. External Examples
Figure 7. Global Hip Osteoarthritis Pain Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Hip Osteoarthritis Pain Drug Consumption Value Market Share by Application in 2022
Figure 9. Medical Care Examples
Figure 10. Personal Care Examples
Figure 11. Global Hip Osteoarthritis Pain Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Hip Osteoarthritis Pain Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Hip Osteoarthritis Pain Drug Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Hip Osteoarthritis Pain Drug Average Price (2018-2029) & (USD/Unit)
Figure 15. Global Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Hip Osteoarthritis Pain Drug Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Hip Osteoarthritis Pain Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Hip Osteoarthritis Pain Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Hip Osteoarthritis Pain Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Hip Osteoarthritis Pain Drug Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Hip Osteoarthritis Pain Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Hip Osteoarthritis Pain Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Hip Osteoarthritis Pain Drug Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Hip Osteoarthritis Pain Drug Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Hip Osteoarthritis Pain Drug Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Hip Osteoarthritis Pain Drug Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Hip Osteoarthritis Pain Drug Average Price by Type (2018-2029) & (USD/Unit)
Figure 30. Global Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Hip Osteoarthritis Pain Drug Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Hip Osteoarthritis Pain Drug Average Price by Application (2018-2029) & (USD/Unit)
Figure 33. North America Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Hip Osteoarthritis Pain Drug Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Hip Osteoarthritis Pain Drug Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Hip Osteoarthritis Pain Drug Consumption Value Market Share by Region (2018-2029)
Figure 53. China Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Hip Osteoarthritis Pain Drug Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Hip Osteoarthritis Pain Drug Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Hip Osteoarthritis Pain Drug Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Hip Osteoarthritis Pain Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Hip Osteoarthritis Pain Drug Market Drivers
Figure 74. Hip Osteoarthritis Pain Drug Market Restraints
Figure 75. Hip Osteoarthritis Pain Drug Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Hip Osteoarthritis Pain Drug in 2022
Figure 78. Manufacturing Process Analysis of Hip Osteoarthritis Pain Drug
Figure 79. Hip Osteoarthritis Pain Drug Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
More Publications
Global Clofarabine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
US$ 3,480.00
November 2018
104 pages
Global Nanomedicines Market 2024 by Company, Regions, Type and Application, Forecast to 2030
US$ 3,480.00
December 2024
110 pages
Global Medical Tapes Market by Manufacturers, Countries, Type and Application, Forecast to 2023
US$ 3,480.00
March 2018
107 pages
Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Blood Bags Market 2018 Forecast to 2023
US$ 4,880.00
May 2018
100 pages
Global Burn Care Treatment Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
US$ 3,480.00
July 2022
109 pages
